Psychedelics at a Turning Point: The Trials That Could Change Mental Health Treatment

from WTR Healthcare Happenings · host Joe Brunetto

Robert Sassoon, WTR Senior Healthcare Analyst, joins Shawn Severson, CEO of WTR, to break down the latest clinical readouts in advanced psychedelics — including Compass Pathways’ Phase III progress in treatment-resistant depression, new anxiety data from Helus, and the upcoming milestones that could shape the future of mental health treatment. From durability and dosing models to regulatory momentum and investor implications, this episode explores why 2026 may be a pivotal year for the field.

Episode metadata supplied by the publisher feed · Published Mar 20, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

Psychedelics at a Turning Point: The Trials That Could Change Mental Health Treatment

0:00 13:28

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of WTR Healthcare Happenings?

This episode is 13 minutes long.

When was this WTR Healthcare Happenings episode published?

This episode was published on March 20, 2026.

Can I download this WTR Healthcare Happenings episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!